Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glibenclamide induced photosensitivity.

Archana Singal1, S N Bhattacharya, M C Baruah

  • 1Department of Dermatology and STD, University College of Medical Sciences and Guru Teg Bahadur Hospital Shadara, Delhi-110 095, India. archanasingal@hotmail.com

Indian Journal of Dermatology, Venereology and Leprology
|July 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased Post-Covid 2019 burden of gonorrhea at a tertiary care hospital in Delhi: Cause for concern.

Indian journal of sexually transmitted diseases and AIDS·2026
Same author

Utility of Cytopathology in Diagnosing a Plethora of Fungal Infections.

Journal of cytology·2026
Same authorSame journal

Patch testing in India: Are we missing clinically relevant allergens?

Indian journal of dermatology, venereology and leprology·2026
Same author

Vitamins and nail: In health and diseases.

Clinics in dermatology·2026
Same author

Reflecting on three years as IJDVL editor.

Indian journal of dermatology, venereology and leprology·2026
Same author

Pigmented condyloma acuminata.

Indian journal of sexually transmitted diseases and AIDS·2025

A 54-year-old man experienced photodermatitis after taking glibenclamide, a second-generation sulfonylurea. This case highlights a rare but significant side effect of this common diabetes medication.

Area of Science:

  • Dermatology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetes mellitus is a common metabolic disorder.
  • Sulfonylureas are frequently prescribed for type 2 diabetes management.
  • Adverse drug reactions can impact patient safety and treatment adherence.

Purpose of the Study:

  • To report a case of photodermatitis associated with glibenclamide.
  • To raise awareness of this infrequently documented side effect.
  • To contribute to the understanding of glibenclamide's adverse event profile.

Main Methods:

  • Case report of a 54-year-old male patient.
  • Clinical observation of photodermatitis development.
  • Review of patient's medication history, specifically glibenclamide use.

Related Experiment Videos

Main Results:

  • The patient developed photodermatitis after ingesting glibenclamide.
  • The reaction was attributed to glibenclamide, a second-generation sulfonylurea.
  • No other causative factors were identified for the photosensitivity.

Conclusions:

  • Glibenclamide can cause photodermatitis, a rare side effect.
  • Healthcare providers should be aware of this potential adverse reaction.
  • Further investigation into sulfonylurea-induced photosensitivity may be warranted.